NYSE:VNEVeoneer Stock Price, Forecast & News

Veoneer's stock was trading at $8.99 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, VNE shares have increased by 17.6% and is now trading at $10.57. View which stocks have been most impacted by Coronavirus.

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Veoneer in the last year. There are currently 7 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Veoneer.

Veoneer is scheduled to release its next quarterly earnings announcement on Friday, July 24th 2020. View our earnings forecast for Veoneer.

Veoneer Inc (NYSE:VNE) released its quarterly earnings data on Friday, April, 24th. The company reported ($1.49) earnings per share for the quarter, missing the consensus estimate of ($1.34) by $0.15. The firm earned $362 million during the quarter, compared to analysts' expectations of $359 million. Veoneer had a negative return on equity of 29.08% and a negative net margin of 33.63%. View Veoneer's earnings history.

Veoneer updated its first quarter 2020 Pre-Market earnings guidance on Friday, March, 20th. The company provided EPS guidance of for the period. The company issued revenue guidance of $350-370 million, compared to the consensus revenue estimate of $390.09 million.

9 analysts have issued 1 year price objectives for Veoneer's shares. Their forecasts range from $9.00 to $26.00. On average, they anticipate Veoneer's stock price to reach $15.38 in the next year. This suggests a possible upside of 45.5% from the stock's current price. View analysts' price targets for Veoneer.

News stories about VNE stock have trended somewhat positive on Monday, InfoTrie Sentiment reports. The research group ranks the sentiment of media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Veoneer earned a coverage optimism score of 1.0 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the next several days. View the latest news aboutVeoneer.

Some companies that are related to Veoneer include Allison Transmission (ALSN), LCI Industries (LCII), Dorman Products (DORM), Dana (DAN), Adient (ADNT), Meritor (MTOR), Gentherm (THRM), Delphi Technologies (DLPH), Standard Motor Products (SMP), American Axle & Manufact. (AXL), Tower International (TOWR), Stoneridge (SRI), Tenneco (TEN), Garrett Motion (GTX) and Motorcar Parts of America (MPAA). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Veoneer investors own include Pfizer (PFE), Autoliv (ALV), Franklin Resources (BEN), Canadian Natural Resources (CNQ), Constellation Pharmaceuticals (CNST), California Resources (CRC), Dominion Energy (D), Delta Air Lines (DAL), Enterprise Products Partners (EPD) and Gilead Sciences (GILD).

Veoneer trades on the New York Stock Exchange (NYSE) under the ticker symbol "VNE."

Veoneer's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (1.92%), DNB Asset Management AS (1.59%), State Street Corp (0.37%), Invesco Ltd. (0.31%), JPMorgan Chase & Co. (0.29%) and Swiss National Bank (0.18%). Company insiders that own Veoneer stock include Arthur Blanchford, Jan Carlson, Mathias Hermansson and Mikko S Taipale. View institutional ownership trends for Veoneer.

VNE stock was sold by a variety of institutional investors in the last quarter, including Deutsche Bank AG, Two Sigma Investments LP, Bank of New York Mellon Corp, Engineers Gate Manager LP, Tudor Investment Corp Et Al, Victory Capital Management Inc., and Victory Capital Management Inc.. View insider buying and selling activity for Veoneer.

VNE stock was bought by a variety of institutional investors in the last quarter, including DNB Asset Management AS, JPMorgan Chase & Co., Invesco Ltd., Jane Street Group LLC, State Street Corp, Aigen Investment Management LP, FNY Investment Advisers LLC, and GSA Capital Partners LLP. Company insiders that have bought Veoneer stock in the last two years include Arthur Blanchford, Jan Carlson, Mathias Hermansson, and Mikko S Taipale. View insider buying and selling activity for Veoneer.

Shares of VNE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of VNE stock can currently be purchased for approximately $10.57.

Veoneer has a market capitalization of $1.18 billion and generates $1.90 billion in revenue each year. The company earns $-500,000,000.00 in net income (profit) each year or ($4.92) on an earnings per share basis. Veoneer employs 8,600 workers across the globe.

The official website for Veoneer is www.veoneer.com.

Veoneer's mailing address is 26545 AMERICAN DRIVE, SOUTHFIELD MI, 48034. The company can be reached via phone at 248-223-0600 or via email at [email protected]